A major pharmaceutical company is warning Canadians about black market sales of an ‘unapproved and illegal’ obesity drug.
Daniel Otis is a journalist at CTVNews.ca. He covers a diverse range of topics including climate change and the environment, aviation and aerospace, as well as retail and competitive sports, often focusing on climate policy, ClimateTech, and space travel. Daniel's work has been featured in notable outlets such as CTV News Toronto, CP24 Breaking News, and BNN Bloomberg.